Due to NRPs regenerative properties, it has the potential to be efficacious for many central nervous system diseases.
Some of CuroNZ's target diseases are the following:
Disease |
Cases Per Year (USA) |
Market Size in US$ |
Effective |
6000 |
$150m |
No |
|
800,000 |
$3.5b |
No |
|
800,000 |
$2.5b |
Yes and No |
|
Traumatic Brain Injury |
1,000,000 |
$1b |
No |
20,000,000 |
$50b |
Yes and No |
CNS Biology

![]() |
"Pearl Chain" like Migration Diagram showing NRP provoking a “pearl-chain”-like migration (arrows) over a few millimeters originating from the thalamic tissue heading towards neocortical tissue. The in vitro assay used postnatal rat CNS-derived brain slices cultivated on coverslips. |
